Breaking News - The Fly

Open Search

ASND

Ascendis Pharma

$

()

Ascendis Pharma announces MRHA approval of YORVIPATH in Great Britain

ASND

4/24/2024 - 08:32am

Ascendis, MoonLake Immunotherapeutics removed from Best Ideas List at Wedbush

ASND , MLTX

3/21/2024 - 08:33am

Ascendis Pharma price target raised by $64 at Wells Fargo, here's why

ASND

3/15/2024 - 07:20am

Ascendis Pharma price target raised by $18 at Wedbush, here's why

ASND

2/8/2024 - 07:48am

Ascendis Pharma price target raised by $36 at Citi, here's why

ASND

2/8/2024 - 06:39am

Ascendis Pharma announces formation, launch with Frazier Life of Eyconis

ASND

1/29/2024 - 08:47am

Ascendis Pharma price target raised by $23 at TD Cowen, here's why

ASND

1/10/2024 - 07:34am

Ascendis Pharma, Vector Pharma FZCO enter exclusive distribution agreement

ASND

1/8/2024 - 08:39am

Specialised Therapeutics signs exclusive agreement with Ascendis Pharma

ASND

1/7/2024 - 14:01pm

Ascendis Pharma announces new analyses from OLE portions of ACcomplisH

ASND

12/20/2023 - 08:33am

Ascendis Pharma price target raised by $2 at Wedbush, here's why

ASND

12/20/2023 - 08:12am

Ascendis Pharma price target raised by $23 at TD Cowen, here's why

ASND

12/20/2023 - 07:28am

Ascendis Pharma price target raised by $5 at BofA, here's why

ASND

12/20/2023 - 06:57am

Ascendis Pharma initiated with bullish view at Jefferies, here's why

ASND

12/20/2023 - 05:35am

Ascendis Pharma price target raised by $5 at BofA, here's why

ASND

12/19/2023 - 20:13pm